Biodegradation of injectable silk fibroin hydrogel prevents negative left ventricular remodeling after myocardial infarction

Biomaterials Science
Yusuke Kambe, Tetsuji Yamaoka

Abstract

In the present study, we investigated the optimal material properties of a tunable hydrogel for the treatment of myocardial infarction (MI) along with the therapeutic mechanism. We developed silk fibroin (SF) hydrogels with the same physical properties (e.g., stiffness) but different biodegradation rates via a peptide modification and evaluated the effect of hydrogel biodegradation on the prevention of negative left ventricular (LV) remodeling in a rat model of MI. LV enlargement was attenuated to a greater extent by injection of a slowly degrading unmodified SF hydrogel as compared to a rapidly degrading peptide-modified SF (SF + Pep) hydrogel for up to 12 weeks post-injection. This could not be explained by the mechanical stabilization of the LV wall by the injectant since the SF and SF + Pep hydrogels degraded completely within 4 weeks and the two groups showed no difference in LV wall thickness at 12 weeks. The SF group had dense randomly aligned collagen fibers whereas the SF + Pep group had sparse fibers surrounding the LV. These results suggest that randomly aligned fibrous tissues formed during/after biodegradation of a slowly degrading SF hydrogel may be more resistant to LV pressure and thus prevent LV enlargement.

References

May 11, 2004·Biomacromolecules·Ung-Jin KimDavid L Kaplan
Oct 27, 2006·The Journal of Physical Chemistry. B·Akira MatsumotoDavid L Kaplan
Nov 23, 2007·Biomaterials·Xiaoqin WangDavid L Kaplan
Oct 7, 2009·Biophysical Journal·Tuna YucelDavid L Kaplan
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jamie L IfkovitsJason A Burdick
Apr 27, 2011·Biomacromolecules·Keiji NumataTakamasa Sakai
Oct 1, 2011·Nature Protocols·Danielle N RockwoodDavid L Kaplan
Dec 14, 2011·Journal of the American College of Cardiology·Aboli A Rane, Karen L Christman
Dec 3, 2014·Acta Biomaterialia·Xiaoqin WangDavid L Kaplan
Apr 4, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hassan K AwadaYadong Wang
Jul 21, 2015·Journal of Biomedical Materials Research. Part a·Yusuke KambeTsunenori Kameda
Dec 19, 2016·International Journal of Pharmaceutics·Laura SaludasMaría Blanco-Prieto
Jan 29, 2017·Journal of Biomedical Materials Research. Part a·Atsushi MaharaTetsuji Yamaoka
May 8, 2018·Macromolecular Bioscience·Brisa PeñaDaewon Park
Sep 22, 2018·Advanced Healthcare Materials·Chris HollandF Philipp Seib
Sep 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yusuke KambeTetsuji Yamaoka

❮ Previous
Next ❯

Citations

Jul 20, 2020·Bio-medical Materials and Engineering·Yusuke KambeTetsuji Yamaoka
Sep 18, 2020·Advanced Healthcare Materials·Yu SongLin Wang
May 28, 2020·Frontiers in Bioengineering and Biotechnology·Giada CattelanCristina Caffarra Malvezzi
Apr 17, 2020·Frontiers in Bioengineering and Biotechnology·Xiaoshan LiaoMiaomiao Yuan
Aug 4, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yusuke KambeTetsuji Yamaoka
Mar 31, 2021·Biomacromolecules·Elisabeth PrinceEugenia Kumacheva
Jun 5, 2021·Acta Biomaterialia·Yusuke Kambe, Tetsuji Yamaoka
Sep 24, 2021·Biomaterials Science·Natalia GorenkovaF Philipp Seib

❮ Previous
Next ❯

Software Mentioned

FiberOri8S03
ImageJ

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Esther WenkLorenz Meinel
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Taiichi WakiyaKoichi Mizuta
© 2021 Meta ULC. All rights reserved